| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2009 | 2011 | ||||||||
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase | 0.716 | 0.423 | 1.6E-07 |
|
disease | 0.340 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 3B | 0.678 | 0.423 | 2.5E-07 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
colony stimulating factor 2 receptor subunit beta | 0.705 | 0.423 | 0.18 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
cardiomyopathy associated 5 | 0.711 | 0.423 | 1.3E-54 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
glutamate ionotropic receptor kainate type subunit 4 | 0.678 | 0.423 | 0.11 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2012 | 2019 | ||||||||
|
adenylate cyclase 7 | 0.656 | 0.462 | 9.5E-07 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2012 | ||||||||
|
coiled-coil and C2 domain containing 1A | 0.628 | 0.462 | 8.5E-03 |
|
disease | 0.310 | None | 0.500 | 2 | 0 | 2010 | 2010 | ||||||||
|
myelin transcription factor 1 like | 0.659 | 0.462 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2010 | 2012 | ||||||||
|
inter-alpha-trypsin inhibitor heavy chain 1 | 0.691 | 0.462 | 2.1E-31 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2013 | 2014 | ||||||||
|
glycosyltransferase 8 domain containing 1 | 0.711 | 0.462 | 1.1E-08 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2013 | 2014 | ||||||||
|
vesicle associated membrane protein 2 | 0.650 | 0.462 | 0.89 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
corticotropin releasing hormone binding protein | 0.659 | 0.500 | 0.21 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2003 | 2007 | ||||||||
|
karyopherin subunit alpha 3 | 0.736 | 0.500 | 0.95 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit V2 | 0.610 | 0.500 | 5.6E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
solute carrier family 17 member 6 | 0.678 | 0.500 | 0.16 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
QKI, KH domain containing RNA binding | 0.617 | 0.500 | 0.75 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
glutamate metabotropic receptor 7 | 0.628 | 0.538 | 1.00 |
|
disease | 0.490 | None | 0.800 | 5 | 0 | 2010 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2006 | 2017 | ||||||||
|
ring finger protein 41 | 0.674 | 0.538 | 0.97 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
translocase of outer mitochondrial membrane 40 | 0.590 | 0.538 | 0.99 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
NADH:ubiquinone oxidoreductase core subunit V1 | 0.617 | 0.538 | 6.4E-11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
2'-5'-oligoadenylate synthetase 2 | 0.670 | 0.538 | 2.6E-21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
TEF transcription factor, PAR bZIP family member | 0.686 | 0.538 | 0.63 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2014 | 2017 |